X-Chem is the industry-leading provider of DNA-Encoded Library (DEL)-based discovery services. DEL technology, allowing customers to screen billions of compounds simultaneously against a single biological target, is an innovative and high growth segment of the market as pharmaceutical companies look for access to cutting edge scientific expertise to support an increasingly challenging drug discovery process. From its Waltham, US headquarters and leveraging a proprietary DEL platform with libraries containing over 200 billion small molecules, X-Chem has supported drug discovery programs for partners throughout the US, Europe and Japan and has licensed over seventy research programs, comprising hundreds of novel chemical entities, to companies.

all, Outsourced Services, Current
Investment date
June 2020
Deal status
Our portfolio